In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs.
Mayo Clinic Proceedings.
Times cited: 73
CALGB 150905 (Alliance): rituximab broadens the antilymphoma response by activating unlicensed NK cells.
Cancer Immunology Research.
Times cited: 25
FDG-PET Lymphoma Demonstration Project Invitational Workshop.
Times cited: 21